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Purpose. The main purpose is to define more accurately the epileptogenic zone (EZ) with noninvasive methods in those patients
with MRI diagnosis of focal cortical dysplasia (FCD) and epilepsy who are candidates of epilepsy surgery. Methods. Twenty patients
were evaluated prospectively between 2007 and 2010 with comprehensive clinical evaluation, video-electroencephalography,
diffusion tensor imaging (DTI), and high-resolution EEG to localize the equivalent current dipole (ECD). Key Findings. In 11 cases
with white matter asymmetries in DTI the ECDs were located next to lesion on MRI with mean distance of 14.63 millimeters with
topographical correlation with the EZ. Significance. We could establish a hypothesis of EZ based on Video-EEG, high-resolution
EEG, ECD method, MRI, and DTI. These results are consistent with the hypothesis that the EZ in the FCD is complex and is often
larger than visible lesion in MRI.
1. Introduction
Drug-resistant epilepsy is associated with malformations
of cortical development (MCD) in 15–20% of adult cases
and in more than 50% of pediatric patients [1–3]. MCD
are a heterogeneous group of focal and diffuse anatomical
derangements whose pathological features depend largely on
the timing of the defect in the developmental process and
to a lesser extent on its cause [4, 5]. Focal cortical dysplasia
(FCD) is the most frequent type of MCD. Taylor et al.
(1971) were the first to describe them as focal anomalies of
cortical structure [6]. Numerous classifications of FCD have
been proposed; a consensus clinic-pathological classification
has been recently published [7]. However, it is widely
recognized that existing classifications are unsatisfactory to
define a prognosis [8, 9]. Furthermore, the etiology of
these abnormalities is often uncertain and the mechanisms
generating epilepsy are also unclear [10]. Several studies
reported that FCD are intrinsically epileptogenic and most
patients often present drug resistant epilepsy [11–16]. Some
authors described the epileptogenic zone (EZ) as focal [17],
while others suggest a more complex network extending
beyond the lesion, an “epileptogenic network” [18]. Resective
surgery is frequently a promising therapy in this population.
However, the outcome following surgical treatment of these
patients has been less successful than in other pathologies
such as hippocampal sclerosis, even if the entire magnetic
resonance images (MRIs) visible lesion is removed [19].
The surgical failure in these patients may be due to the
difficulty in defining the epileptogenic zone, which can
be more extensive involving apparently normal cortical
areas in MRI [20]. The key for the success of surgical
treatment is the accurate definition of the “epileptogenic
zone” (EZ), the area of cortex that is indispensable for
the generation of epileptic seizures and which removal
or disconnection achieved seizure-free [21–24]. Today the
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gold-standard method to define the EZ is the intracranial
recording, an invasive procedure that increases morbidity
and mortality. In addition, it demands an important amount
of materials and human resources. These facts reduce the
number of patients undergoing epilepsy surgery, which is
below the number of cases for whom it is indicated. This
situation is especially notorious in developing countries. In
this scenario, noninvasive studies to define EZ are highly
desirable [25]. The study of the EZ involves also the
“irritative zone” (IZ), the area of cortex responsible for the
scalp electroencephalography (EEG) interictal spikes (IISs).
Both of these zones are also related to the onset zone of
seizures [21, 22]. IIS neural sources can be located solving the
so-called inverse problem with an equivalent current dipoles
(ECDs) model. The ECD based on scalp EEG is the most
often used model for noninvasively estimating the source of
cerebral activity, specially to localize the origin of IIS activity
[26–28]. The application of this model in patients with
epilepsy and FCD was reported in using EEG [13, 22, 29] and
using magnetoencephalography (MEG) [13, 14, 30, 31].
In this study we analyze a group of patients with epilepsy
and FCD diagnosed by MRI. The main purpose is to obtain
as much information as possible to delineate more accurately
the hypothetical EZ with noninvasive methods in those
patients who are candidates to epilepsy surgery. In these
patients the EZ is suspected by ictal semiology and lesion
seen in MRI. We applied ECD model treating to define more
accurately the EZ and see the relative spatial distribution of
ECDs as sources localized from single IIS, using 64-channel
scalp EEG.
Twenty patients with diagnosis of epilepsy secondary
to FCD according to MRI criteria [32, 33] were evaluated
prospectively at the Epilepsy Center, Ramos Mejı́a Hospital
between 2007 and 2010. At baseline all patients had resistant
epilepsy, according to the new published criteria [34], with
great impact on their quality of life. Two subjects improved
seizure control after changes in antiepileptic drugs.
All included patients had a neurological examina-
tion, neuropsychological testing, routine MRI, and video-
electroencephalography (V-EEG) with 32 channels, except
those who became seizure-free (n = 2). Medical records
were reviewed to identify (a) potential risk factors for
the development of epilepsy, including prenatal trauma,
perinatal bleed or infection, complicated delivery, childhood
febrile seizures, head trauma, or family history of seizures,
(b) ictal semiology according to the V-EEG and in the two
subjects who became seizure free, the patient and relative’s
history were taking account, (c) sex, (d) age at seizure onset,
(e) ictal semiology [35], and (f) response to treatment was
considered in relation to seizure frequency [34].
All patients had conventional MRI criteria suggesting
FCD including gyration anomalies, focal thickenings of the
cortex, blurring of the grey-white matter junction, and
abnormal cortical and subcortical signal intensity [32, 33].
The MRIs were evaluated retrospectively by two neurologists
blind to the study. We assumed that FCDs are subtype
II, according to the new ILAE classification [7]; since
such kind of FCD is easier to detect by MRI, certain
diagnosis it is possible only with histopathological data.
The structure of white matter was evaluated by Diffusion
Tensor Imaging (DTI) which is an MRI technique that can
be used to indirectly evaluate the integrity of the axonal
microenvironment by measuring the diffusion of water and
its directionality in three dimensions [36]. Then, taking into
account the findings of asymmetry of white matter structure
in DTI, we selected a subset of patients for performing the
ECD method.
The study was approved by the research ethics committee
of the Ramos Mejı́a Hospital. Patients (and parents) gave
their informed consent accepting the procedures in this study
and the use of the information.
1.1. High-Resolution EEG and ECD. We recorded high-
resolution EEG (HR-EEG) data from each patient with a
64-channel amplifier Bioscience EEG64 (Bioscience SRL,
Argentina). Hardware filter frequency bandpass was 0.5–
70 Hz (−3 dB) and sampling rate was set to 200 Hz. Har-
monie 5.2 software (Stellate Systems Inc., Canada) was
used to acquire data. Scalp electrodes were mounted on
an Electro-Cap according to the international 10-10 system
of electrode placement (including F9/10, FT9/10, T9/10,
TP9/10, and P9/10) (Bio-Logic Systems Corp, USA). Record-
ings were referenced to average mastoidal electrodes. During
acquisition sessions, patients were relaxed and asked to lie
down with closed eyes for 3 hours in a sound attenuated
and electrical shielded room. Before EEG recording started,
we registered spatial coordinates of all electrodes and of
three fiduciary landmarks (nasion, right and left tragi) with
a three-dimension digitizer system PATRIOT (Polhemus,
USA) and 3D Electrode Acquisition software developed
by our group. Two position sensors were used, namely, a
primary pen type sensor to acquire electrode and fiduciary
points and a secondary sensor, fixed to the cap, as a position
reference. After acquiring all electrode and fiducial positions,
our software showed all the points on a 3D plot (Figure 1(a)).
1.2. Image Acquisition and Processing. In a second instance,
patients were scanned with the same 1.5 T MRI unit
(Intera, Philips Medical Systems, Best, The Netherlands).
The acquired images were structural high-resolution 3D,
T1-weighted spoiled gradient recovery volume (TR/TE/TI
= 9.2/4.2/450 ms, matrix 256 × 256, bandwidth 31.2 kHz,
field of view 256 mm × 256 mm, slice thickness 1 mm)
with a final isotropic resolution of 1 mm. Depending on
head sizes, approximately 160 slices in the axial plane were
acquired and stored in DICOM format. Then, a 3D volume
reconstruction, designated T1Vol from now on, was made of
each patient head using MRIcron software (Chris Rorden’s
MRIcron, USA) in NIfTI format. A high-resolution mesh
of 32768 triangles of the scalp surface was subsequently
constructed from this volume using an iterative morphing
algorithm in BrainVoyager2000 software (Brain Innovation,
The Netherlands). In addition, all subjects were scanned
with a 2D fluid attenuated inversion recovery (FLAIR)
sequence (TR/TE/TI = 10,000/147/2200 ms, matrix 192 ×
256, bandwidth 15.6 kHz, field of view 240 cm× 240 cm, slice
thickness between 4 and 5 mm, no gap) in the coronal and
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Figure 1: (a) 3D plot of electrodes and fiducial locations in a 3D virtual space in 3D electrode acquisition. (b) Left frontal FCD marked in
Brain Voyager (red) overlaid on anatomical reconstruction with average dipole (green) near the lesion (distance: 4.47 mm). (c) An example
of localization with BESA software.
axial planes. The integrity of white matter was also evaluated
by means of DTI.
1.3. Lesion Marking and Processing. The more sensitive
FLAIR sequence overlaid into the high-resolution T1 was
mainly used to depict the shape and location of the lesion.
Using a volume of interest (VOI) pen tool in MRIcron,
an experienced neuroradiologist (J. P. Princich) marked
the voxels corresponding to the suspected FCD on each
slice (axial, sagittal, and coronal) (Figure 1(b)) according to
previously established criteria [32, 37]. Thus, we obtained the
set of voxels enclosing the anatomical lesion for each subject.
These VOIs-denoted by LesionVol, were then converted to
NIfTI format in the same coordinate system as T1Vol.
Finally, using Matlab (The MathWorks, USA), a surface mesh
describing the lesion border was constructed and its center of
mass was calculated.
1.4. Registration of Electrodes and Fiducials with MRI. The
electrode position coordinate system needs to be coregistered
with T1Vol and LesionVol space. For that purpose, we marked
fiduciary landmarks on the scalp mesh surface and fitted the
electrode coordinates to lay on the mesh, via a rigid body
transformation in BrainVoyager2000. Fiduciary points were
constrained to depart no further than 3 mm from the original
position during the fitting procedure to avoid unfeasible
electrode locations.
1.5. Selection of IIS. According to IFSECN criteria [38] we
visually identified and selected IISs based on negative phase
reversals on bipolar montages. The IISs were classified by
morphology and frequency as single sharp waves or spikes,
polyspikes, repetitive discharges lasting one or more seconds,
or continuous discharges occupying more than 80% of the
record. A sharp wave or spike was considered epileptiform if
it had a sharp contour, duration of less than 200 msec and
was clearly distinguished from ongoing background activity
by its amplitude and duration [38]. When different types
of IISs were found, they were collected in different groups.
IISs were also classified according to spatial anatomical
distribution as regional (maximum over a single lobe or
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in two contiguous regions), multiregional (involving two
or more regions in more than one lobe), or generalized.
Afterwards, IISs were extracted in epochs of 400 ms (200 ms
before and after the highest amplitude) and loaded into
Matlab. Finally, signal-to-noise ratio (SNR) of every single
IIS was calculated as the mean power of the spike interval
over the mean power of the background activity. IISs with
SNR smaller than 1.5 were discarded. We observe that no IIS
data was averaged.
1.6. ECD Localization of IIS Neural Sources. IISs epochs were
analyzed using Source Analysis module of Brain Electrical
Source Analysis v5.1 (BESA) software (MEGIS Software
GmbH, Germany). A high-pass filter at 3 Hz and a low-
pass filter at 40 Hz were applied to all channels. Source
localization for each single IIS was obtained solving the
inverse problem with an ECD model of fixed location, fixed
orientation, and time-varying amplitude. A four-shell ellip-
soidal head model was used to solve the direct problem using
the coregistered electrode position information. This model
is utilized to compute the electric potential distribution on
the scalp and to compare the values at the electrode locations
with the actual measurements. Each of the layers in the
model was assumed to have a constant value of homogeneous
and isotropic conductivity relative to CSF.
2. Methods
2.1. Patients Selection. We assumed focal epileptogenic
sources in these patients; therefore the source localization
procedure was set to estimate a single focal source with one
ECD. For each IIS the ECD was calculated fitting the zone of
maximum energy (approximately ±6 ms from peak). When
the first component of the principal component analysis
(PCA) of the signal was larger than 90% the dipole was
declared valid, and when it was less, the IIS was discarded.
2.2. Analysis of ECDs and FCD. Using the coregistration
information, we overlaid in the same space ECDs, T1Vol, and
lesion surface mesh in Matlab (Figures 1(b) and 1(c)). We
devised and calculated several different indicators with the
objective of measuring the performance of source localiza-
tion when comparing source with hypothetical epileptogenic
lesion locations. First, from all ECDs of a single individual, an
average dipole (AD) was defined, with the average location
and orientation. Then, in terms of spatial distance to the
MRI lesion, three indicators were measured: the distance
from the AD to the lesion border (AD-L) and the mean of
the distance from each ECD to the lesion border (ECD-L)
and also the standard deviation from ECD-L (SD ECD-L).
Individual ECD dispersion (Di) was calculated as the mean
distance of each ECD to the AD. The smaller this value is the
higher is the concentration of dipoles about AD.
2.3. Diffusion Tensor Imaging (DTI). DTI studies of the
central nervous system rely on the phenomenon that water
diffusion is anisotropic (i.e., highly ordered and tightly
packed) in the normal white matter and are also the raw data
to perform fibre tractography. Numerous model and clinical
research studies have shown that DTI is sensitive to underly-
ing abnormalities that are not apparent on conventional MR
images [39, 40]. Fractional Anisotropy (FA) is an invariant
rotational DTI index that can be quantified in each voxel with
values ranging from zero (isotropic diffusion) to one (highly
anisotropic diffusion). Reduced FA has been reported in the
subcortical white matter underlying cortical abnormalities
including FCD patients [40, 41], with anomalies extending
even beyond the obvious cortical abnormality seen with
conventional MRI [36, 42].
All patients were scanned consecutively since 2007 in the
same MRI Unit at 1.5T (Intera, Philips Medical Systems,
Best, Netherlands) using a six-channel head antenna with
a (SENSE) “Sensitivity Encoding” factor of 2 for a single-
shot diffusion-weighted echo planar imaging (TR/TE =
6,860/102 ms, matrix 128 × 128, bandwidth 95 KHz, field of
view 22 × 22 cm2), with a b value of (800 s/mm2) applied
sequentially in 32 non-collinear directions; at 60–70 axial
slice positions one B0 image was acquired with no diffusion
gradient applied at each slice location (2 mm thickness, no
gap, and NSA: 3), with total scan time around 16-minute
duration giving an in-plane reconstructed isotropic resolu-
tion of 2 mm. FA images of each subject were coregistered
and resliced to their own high-resolution T1 3D and FLAIR
images using SPM5 software from the Welcome Trust Centre
for Neuroimaging (http://www.fil.ion.ucl.ac.uk/spm/). The
evaluation of FA images overlaid to the T1 3D and FLAIR
images was paired and assisted with the directional color
maps projected on axial, sagital, and coronal planes using
the DTI module of MedINRIA software (MedINRIA v1.7:
Medical Image Navigation and Research Tool by INRIA).
A qualitative analysis was performed, by two indepen-
dent examiners blinded to clinical and structural MRI find-
ings. The asymmetries between regions were defined when
both examiners agreed. The population was then divided
in two groups, Group A: no asymmetries or representing
mild or not clear focal or regional asymmetries between
hemispheres on FA maps and Group B: with asymmetries,
showing moderate-to-severe focal or regional asymmetries
on FA maps. Both the Group A and Group B results were
matched for age, sex, epilepsy duration, ictal semiology, and
ECD (Figure 2).
3. Results
3.1. Clinical Data. We included 20 patients since 2007–2010.
Mean age of our population was 25.9 years (9–46 years), 7
females, 13 males, they all had a negative family history of
epilepsy, and only two patients had pathological neurological
exam, both with mild contralateral paresis. Past medical
history before epilepsy onset was relevant in 8 patients, five
had febrile seizures (25%), one case a perinatal infection
(5%), and two suffered of perinatal hypoxia/anoxia (10%).
Three patients had mild-to-severe mental retardation.
Mean seizure onset age was 5.71 years (2 months–17
years) and the seizure frequency was 5.1 seizure per month
(0–15). Two patients became seizure-free after adjusting
antiepileptic drugs. Focal seizures were presented in the
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(a) (b)
Figure 2: Group “A” patient with right frontal middle gyrus FCD. (a) Coronal MRI FLAIR, (b) DTI anisotropy maps.
Table 2: Equivalent current dipoles (ECDs) localization results and measurements relative to focal cortical dysplasia (FCD).
Patient ECDs AD-L (mm) Di (mm) ECDs-L (mm) SD ECD-L (mm) Mean SNR Mean GoF
1 4 4.63 12.96 7.55 10.37 2.8 77.95
2 34 3.97 13.04 13.29 8.14 4.2 86.23
3 4 3.1 27.47 10.99 6.45 2.59 67.48
4 7 13.57 12.32 16.57 7.52 3.74 83.86
5 9 25.09 16.78 28.17 13.99 3.24 86.05
6 5 1.41 18.49 9.46 4.74 3.97 77.21
7 10 22.9 14.22 25.56 12.98 5.67 74.33
8 12 57.44 14.93 59.53 9.74 2.81 79.48
9 12 19.44 7.23 20.89 3.03 5.45 89.01
10 8 4.72 17.29 6.27 9.22 5.21 64.9
11 3 4.66 28.85 20.96 12.8 2.09 66.53
Total 9.82 14.63 16.69 19.93 9 3.8 77.55
100% of our population. The ictal onset zone was topograph-
ically correlated with the FCD visible by MRI. The initial
semiology was as follows: 7 subjects had focal clonic seizures,
6 patients had focal asymmetrical tonic seizures, 2 patients
had contralateral versive oculocephalic seizures, 3 patients
had dyscognitive phenomena with impairment of memory,
speech, attention, and perception, and one patient had audi-
tory phenomena as initial manifestation and another subject
had hyperkinetic pedal movements. All patients presented
a single seizure type. Seven patients (35%) had secondarily
generalized seizures. In the two cases of seizure free, clinical
semiology was assumed taking account that the story of the
patient and family members committed to their care match.
None of our patients had status epilepticus, epilepsy partialis
continua, or reflex seizures (Table 1).
3.2. MRI. The frontal lobe was affected in 14 cases (70%).
In 10 cases (50%) the dysplastic cortex was located on the
medial aspect of the brain, and there were no cases affecting
both the medial and the lateral surfaces. Three cases involve
at least two lobes. Five cases (25%) have a transmantle char-
acteristics, all of them involving the frontal lobe (Table 1).
3.2.1. DTI. Nine patients (45%) were classified into Group
A (no asymmetries) in the FA maps. Eleven patients (55%)
were included in Group B (with asymmetries) in the FA
maps. in ten of these patients the areas of focal or regional,
subcortical decreased FA were around the FCD exceeding
the structural limits detected on T1/FLAIR sequences.
Three patients had associated widespread areas of increased
or decreased FA which extended beyond the subcortical
regional area of FCD, usually including a different brain lobe.
3.2.2. EEG and ECD. In all cases the interictal EEG shows
focal features. The most common pattern of interictal
activity was stereotyped rhythmic, 4–10 Hz, of repetitive
medium-voltage sharp waves or spikes lasting more than 1
second, present in 12 patients (60%). 16 patients (80%) had
isolated, intermittent sharp waves or spikes. The electrical
field of both EEG phenomena was correlated with the
anatomical location of FCD seen in MRI. A scalp ictal
recording was obtained in 18 cases (90%). The onset of the
ictal discharge was characterized by low-voltage fast activity
in 14 patients (70%) and rhythmic sharp waves or spikes in 4
cases (20%). Ictal activity was focal and coincided with FCD
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location in 10 patients. The ictal activity of FCD located in
medial surface in 8 patients (40%) tends to be more regional
or even has bilateral features.
Eleven out of 20 underwent dipole localization technique
(Table 2). In Table 2 we summarize the localization analysis
for each patient. All dipoles had a signal-noise ratio greater
than 2 and a goodness of fit greater than 60%. The average
number of ECD per patient was 9.82 (3–34). The overall
mean distance between a patient average dipole (AD) to
lesion border was 14.63 millimeters (1.41–57.44) and in 6
cases (54%) it was less than 5 mm. Dispersion of ECD varied
between 7 and 28 mm, with a mean of 16.69 mm. In all cases
ADs were located outside the visible lesion.
Two patients of the series underwent epilepsy surgery
after neurophysiological exploration: one patient with FCD
IIB of the right frontal middle gyrus and the other case with
FCD IIB located in the right frontal pole. Both cases are
seizure free (Engel 1A). The remaining patients in the series
are awaiting surgery, except two subjects who improved
seizure control after changes in antiepileptic drugs.
4. Discussion
Our series of 20 patients with MRI diagnosis of FCD
presented a relatively lower frequency of seizures in relation
to other descriptions [43–46]. All patients, except two who
became seizures free, have drug-resistant epilepsy with a
great impact on quality of life. No cases of status epilep-
ticus, epilepsia partialis continua, and reflex seizures were
observed. A possible explanation for this better course of
epilepsy is that, unlike the other series, our series include
also two patients who became nonsurgical candidates after
adjustment of antiepileptic drugs. Almost all patients began
their seizure at early childhood. All patients presented focal
seizures with clinical semiology concordant with lesional
area seen on MRI. As mentioned by other authors, FCD is
associated with a wide range of clinical presentations [47–
49].
Analysis of IISs seems to be particularly important
for accurately delineation of ZE and an eventual surgical
treatment [50–52]. Bautista et al. [51] concluded that
the presence of interictal epileptiform discharges extending
beyond the area of resection correlates with poor surgical
outcome in patients with extrahippocampal epilepsy. In con-
trast, patients with focal interictal epileptiform discharges
included in surgical resection have good surgical outcomes.
ECD is based on HR-EEG data and allows identifying the
underlying source of a given potential distribution [53]. In
the present study, the mean distance of dipoles to lesion
border was 14.63 mm. The results are consistent with the idea
that the EZ in FCD is often larger than visible lesion in MRI,
involving perilesional “normal appearing” cortex [24, 54]. As
described by other authors, areas of FCD with most signal
changes on MRI are those with balloons cells, while the areas
with dysmorphic or cytomegalic cells generate lower signal
changes on FLAIR sequence [32, 33, 55]. Balloon cells are
electrically silent while dysmorphic and cytomegalic cells
are believed to be the responsible for interictal and ictal
discharges [10, 55–59]. Our findings reinforce the view that
irritative zone, which can be larger than the actual EZ, in
these cases exceeds the lesion visible by MRI and may be
organized as networks beyond the borders of the lesion, or
to more remote zones [18, 60, 61]. Many studies report,
when complete resection of MRI visible lesion, over a 50–
75% seizure-free rate is achieved [62], supporting the idea of
intrinsic epileptogenicity [10, 15, 57, 63], but still leaves 25–
50% of patients with seizures [60, 64, 65] this suggesting that
EZ was not contained within the lesion in those cases. In all
cases, identified ECD could be correlated with hypothesis of
EZ, by ictal semiology, imaging appearance of FCD on MRI,
and visual analysis of topography of paroxysmal activity in
EEG. However we assume, as other authors have done, that
the EZ is complex and may extend in some cases, beyond
the limits of the lesion visible on MRI involving “normal
appearing” perilesional cortex [17, 18, 51, 52, 54, 66, 67].
The importance of these findings is that the complete surgical
removal of the FCD, the parts visible and nonvisible in
MRI, is the main predictive of good outcome after surgery.
Larger studies using ECD are needed as a complementary
technique for delineating the EZ more precisely and planning
less invasive neurophysiological exploration.
Qualitative inspection of DTI is commonly used in
clinical practice and FA maps are applied in different research
protocols to assess the integrity of white matter microstruc-
ture; reduced FA was associated with several pathologic
conditions and not exclusively related to FCD. It could be
a sensitive technique readily available for clinicians for in
vivo assessment of white matter in FCD patients despite the
limitations of visual subjective evaluation. To date, the exist-
ing DTI statistical methods for group analysis have several
limitations [68]. According to previous publications [42],
we have found areas of moderate or severe interhemispheric
asymmetries associated to visible FCD lesion and also found
more marked changes that extend beyond the lesion. These
findings might represent imaging evidence of abnormal
white matter around and beyond the MRI visible FCD. These
findings could explain the complexity of definition of EZ in
these cases and, perhaps, the pattern of spread observed in
EEG [69–71].
A further step in this analysis is to correlate ECD, EZ, and
MRI lesion with postsurgical evolution.
5. Conclusions
The anatomo-electroclinical profile of these patients is
heterogeneous. In those cases with white matter asymmetries
the mean distance of ECD to lesion visible in conventional
MRI was 14.63 mm. This may reflect that the lesion or cortex
areas nearby the lesion are also epileptogenic. These results
are consistent with the view that the irritative zone in these
cases exceed the lesion visible by MRI and the EZ may be
organized as networks beyond the borders of the lesion or
to more remote zones. With the ECD method we attempt to
delineate more accurately the EZ, with the idea of limiting
a possible neurophysiological exploration and, therefore, the
associated morbidity. DTI is a promising new tool that can
reveal structural white matter abnormalities.
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A less invasive algorithm can be used to assess patients
that are candidates to surgery, trying to reduce the extension
of invasive studies and improving even further the profile of
morbidity.
However, more studies assessing the suitability of all these
techniques are needed to corroborate their better predictive
value and its usefulness in these complex patients.
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